カテゴリー： Market Monitor Global, 世界, 医療/バイオ

自閉症診断の世界市場見通し2023年-2029年

◆英語タイトル：Autism Diagnostic Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5043）

◆商品コード：MMG23JU5043
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：67
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Autism Diagnostic Market 調査レポートは次の情報を含め、グローバルにおけるの自閉症診断市場規模と予測を収録しています。・世界の自閉症診断市場：売上、2018年-2023年、2024年-2029年
・世界の自閉症診断市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の自閉症診断市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「通信&行動療法」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

自閉症診断のグローバル主要企業は、Pfizer, Inc.、 Novartis AG、 Allergan、 Merck&Co Inc.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Teva Pharmaceutical Industries Ltd.、 Johnson&Johnson Services, Inc.、 Bristol–Myer Squibb、 Otsuka Holdings Co., Ltd.、 Actavis, Inc.、 Curemark LLC.、 Mylan Pharmaceuticals、 Asuragen Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、自閉症診断のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の自閉症診断市場：タイプ別、2018年-2023年、2024年-2029年
世界の自閉症診断市場：タイプ別市場シェア、2022年
・通信&行動療法、作業療法、高圧酸素療法、キレート療法、オキシトシン療法、薬物療法、その他

世界の自閉症診断市場：用途別、2018年-2023年、2024年-2029年
世界の自閉症診断市場：用途別市場シェア、2022年
・自閉症、アスペルガー症候群、小児崩壊性障害、その他

世界の自閉症診断市場：地域・国別、2018年-2023年、2024年-2029年
世界の自閉症診断市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における自閉症診断のグローバル売上、2018年-2023年
・主要企業における自閉症診断のグローバル売上シェア、2022年
・主要企業における自閉症診断のグローバル販売量、2018年-2023年
・主要企業における自閉症診断のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer, Inc.、 Novartis AG、 Allergan、 Merck&Co Inc.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Teva Pharmaceutical Industries Ltd.、 Johnson&Johnson Services, Inc.、 Bristol–Myer Squibb、 Otsuka Holdings Co., Ltd.、 Actavis, Inc.、 Curemark LLC.、 Mylan Pharmaceuticals、 Asuragen Inc.

*************************************************************

・調査・分析レポートの概要
自閉症診断市場の定義
市場セグメント
世界の自閉症診断市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の自閉症診断市場規模
世界の自閉症診断市場規模：2022年 VS 2029年
世界の自閉症診断市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの自閉症診断の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の自閉症診断製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：通信&行動療法、作業療法、高圧酸素療法、キレート療法、オキシトシン療法、薬物療法、その他
自閉症診断のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：自閉症、アスペルガー症候群、小児崩壊性障害、その他
自閉症診断の用途別グローバル売上・予測

・地域別市場分析
地域別自閉症診断市場規模 2022年と2029年
地域別自閉症診断売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer, Inc.、 Novartis AG、 Allergan、 Merck&Co Inc.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Teva Pharmaceutical Industries Ltd.、 Johnson&Johnson Services, Inc.、 Bristol–Myer Squibb、 Otsuka Holdings Co., Ltd.、 Actavis, Inc.、 Curemark LLC.、 Mylan Pharmaceuticals、 Asuragen Inc.
...

Autism or autism spectrum disorder (ASD) is a mental disability characterized by challenges with social skills including impaired social behavior, speech and communication.Autism or ASD is the prevailing disabilities. Thus, the early identification, assessment, and diagnosis is the first step toward autism treatment.Autism Diagnostics Market Segmented By type that is Autistic Disorder, Asperger Syndrome and Childhood Disintegrative Disorder.
This report aims to provide a comprehensive presentation of the global market for Autism Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Diagnostic. This report contains market size and forecasts of Autism Diagnostic in global, including the following market information:
Global Autism Diagnostic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autism Diagnostic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Communication and Behavioral Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autism Diagnostic include Pfizer, Inc., Novartis AG, Allergan, Merck&Co Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson&Johnson Services, Inc. and Bristol–Myer Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autism Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autism Diagnostic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autism Diagnostic Market Segment Percentages, by Type, 2022 (%)
Communication and Behavioral Therapy
Occupational Therapies
Hyperbaric Oxygen Therapy
Chelation Therapy
Oxytocin Therapy
Drug Therapies
Others
Global Autism Diagnostic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autism Diagnostic Market Segment Percentages, by Application, 2022 (%)
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Global Autism Diagnostic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autism Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autism Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autism Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Novartis AG
Allergan
Merck&Co Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Johnson&Johnson Services, Inc.
Bristol–Myer Squibb
Otsuka Holdings Co., Ltd.
Actavis, Inc.
Curemark LLC.
Mylan Pharmaceuticals
Asuragen Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autism Diagnostic, market overview.
Chapter 2: Global Autism Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Autism Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autism Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Autism Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autism Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autism Diagnostic Overall Market Size
2.1 Global Autism Diagnostic Market Size: 2022 VS 2029
2.2 Global Autism Diagnostic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autism Diagnostic Players in Global Market
3.2 Top Global Autism Diagnostic Companies Ranked by Revenue
3.3 Global Autism Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Autism Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autism Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autism Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Autism Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Autism Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Autism Diagnostic Market Size Markets, 2022 & 2029
4.1.2 Communication and Behavioral Therapy
4.1.3 Occupational Therapies
4.1.4 Hyperbaric Oxygen Therapy
4.1.5 Chelation Therapy
4.1.6 Oxytocin Therapy
4.1.7 Drug Therapies
4.1.8 Others
4.2 By Type – Global Autism Diagnostic Revenue & Forecasts
4.2.1 By Type – Global Autism Diagnostic Revenue, 2018-2023
4.2.2 By Type – Global Autism Diagnostic Revenue, 2024-2029
4.2.3 By Type – Global Autism Diagnostic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Autism Diagnostic Market Size, 2022 & 2029
5.1.2 Autistic Disorder
5.1.3 Asperger Syndrome
5.1.4 Childhood Disintegrative Disorder
5.1.5 Others
5.2 By Application – Global Autism Diagnostic Revenue & Forecasts
5.2.1 By Application – Global Autism Diagnostic Revenue, 2018-2023
5.2.2 By Application – Global Autism Diagnostic Revenue, 2024-2029
5.2.3 By Application – Global Autism Diagnostic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Autism Diagnostic Market Size, 2022 & 2029
6.2 By Region – Global Autism Diagnostic Revenue & Forecasts
6.2.1 By Region – Global Autism Diagnostic Revenue, 2018-2023
6.2.2 By Region – Global Autism Diagnostic Revenue, 2024-2029
6.2.3 By Region – Global Autism Diagnostic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Autism Diagnostic Revenue, 2018-2029
6.3.2 US Autism Diagnostic Market Size, 2018-2029
6.3.3 Canada Autism Diagnostic Market Size, 2018-2029
6.3.4 Mexico Autism Diagnostic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Autism Diagnostic Revenue, 2018-2029
6.4.2 Germany Autism Diagnostic Market Size, 2018-2029
6.4.3 France Autism Diagnostic Market Size, 2018-2029
6.4.4 U.K. Autism Diagnostic Market Size, 2018-2029
6.4.5 Italy Autism Diagnostic Market Size, 2018-2029
6.4.6 Russia Autism Diagnostic Market Size, 2018-2029
6.4.7 Nordic Countries Autism Diagnostic Market Size, 2018-2029
6.4.8 Benelux Autism Diagnostic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Autism Diagnostic Revenue, 2018-2029
6.5.2 China Autism Diagnostic Market Size, 2018-2029
6.5.3 Japan Autism Diagnostic Market Size, 2018-2029
6.5.4 South Korea Autism Diagnostic Market Size, 2018-2029
6.5.5 Southeast Asia Autism Diagnostic Market Size, 2018-2029
6.5.6 India Autism Diagnostic Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Autism Diagnostic Revenue, 2018-2029
6.6.2 Brazil Autism Diagnostic Market Size, 2018-2029
6.6.3 Argentina Autism Diagnostic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Autism Diagnostic Revenue, 2018-2029
6.7.2 Turkey Autism Diagnostic Market Size, 2018-2029
6.7.3 Israel Autism Diagnostic Market Size, 2018-2029
6.7.4 Saudi Arabia Autism Diagnostic Market Size, 2018-2029
6.7.5 UAE Autism Diagnostic Market Size, 2018-2029
7 Autism Diagnostic Companies Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Autism Diagnostic Major Product Offerings
7.1.4 Pfizer, Inc. Autism Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Autism Diagnostic Major Product Offerings
7.2.4 Novartis AG Autism Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan Autism Diagnostic Major Product Offerings
7.3.4 Allergan Autism Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Allergan Key News & Latest Developments
7.4 Merck&Co Inc.
7.4.1 Merck&Co Inc. Company Summary
7.4.2 Merck&Co Inc. Business Overview
7.4.3 Merck&Co Inc. Autism Diagnostic Major Product Offerings
7.4.4 Merck&Co Inc. Autism Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Merck&Co Inc. Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Autism Diagnostic Major Product Offerings
7.5.4 Eli Lilly and Company Autism Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 F. Hoffmann-La Roche Ltd. Company Summary
7.6.2 F. Hoffmann-La Roche Ltd. Business Overview
7.6.3 F. Hoffmann-La Roche Ltd. Autism Diagnostic Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd. Autism Diagnostic Revenue in Global Market (2018-2023)
7.6.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. Autism Diagnostic Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd. Autism Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.8 Johnson&Johnson Services, Inc.
7.8.1 Johnson&Johnson Services, Inc. Company Summary
7.8.2 Johnson&Johnson Services, Inc. Business Overview
7.8.3 Johnson&Johnson Services, Inc. Autism Diagnostic Major Product Offerings
7.8.4 Johnson&Johnson Services, Inc. Autism Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Johnson&Johnson Services, Inc. Key News & Latest Developments
7.9 Bristol–Myer Squibb
7.9.1 Bristol–Myer Squibb Company Summary
7.9.2 Bristol–Myer Squibb Business Overview
7.9.3 Bristol–Myer Squibb Autism Diagnostic Major Product Offerings
7.9.4 Bristol–Myer Squibb Autism Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Bristol–Myer Squibb Key News & Latest Developments
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Company Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Autism Diagnostic Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Autism Diagnostic Revenue in Global Market (2018-2023)
7.10.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
7.11 Actavis, Inc.
7.11.1 Actavis, Inc. Company Summary
7.11.2 Actavis, Inc. Business Overview
7.11.3 Actavis, Inc. Autism Diagnostic Major Product Offerings
7.11.4 Actavis, Inc. Autism Diagnostic Revenue in Global Market (2018-2023)
7.11.5 Actavis, Inc. Key News & Latest Developments
7.12 Curemark LLC.
7.12.1 Curemark LLC. Company Summary
7.12.2 Curemark LLC. Business Overview
7.12.3 Curemark LLC. Autism Diagnostic Major Product Offerings
7.12.4 Curemark LLC. Autism Diagnostic Revenue in Global Market (2018-2023)
7.12.5 Curemark LLC. Key News & Latest Developments
7.13 Mylan Pharmaceuticals
7.13.1 Mylan Pharmaceuticals Company Summary
7.13.2 Mylan Pharmaceuticals Business Overview
7.13.3 Mylan Pharmaceuticals Autism Diagnostic Major Product Offerings
7.13.4 Mylan Pharmaceuticals Autism Diagnostic Revenue in Global Market (2018-2023)
7.13.5 Mylan Pharmaceuticals Key News & Latest Developments
7.14 Asuragen Inc.
7.14.1 Asuragen Inc. Company Summary
7.14.2 Asuragen Inc. Business Overview
7.14.3 Asuragen Inc. Autism Diagnostic Major Product Offerings
7.14.4 Asuragen Inc. Autism Diagnostic Revenue in Global Market (2018-2023)
7.14.5 Asuragen Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Autism Diagnostic Market Opportunities & Trends in Global Market
Table 2. Autism Diagnostic Market Drivers in Global Market
Table 3. Autism Diagnostic Market Restraints in Global Market
Table 4. Key Players of Autism Diagnostic in Global Market
Table 5. Top Autism Diagnostic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autism Diagnostic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autism Diagnostic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autism Diagnostic Product Type
Table 9. List of Global Tier 1 Autism Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autism Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Autism Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Autism Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autism Diagnostic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Autism Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Autism Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autism Diagnostic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Autism Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Autism Diagnostic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autism Diagnostic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Autism Diagnostic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autism Diagnostic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Autism Diagnostic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autism Diagnostic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Autism Diagnostic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autism Diagnostic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Autism Diagnostic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autism Diagnostic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Autism Diagnostic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autism Diagnostic Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer, Inc. Company Summary
Table 31. Pfizer, Inc. Autism Diagnostic Product Offerings
Table 32. Pfizer, Inc. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer, Inc. Key News & Latest Developments
Table 34. Novartis AG Company Summary
Table 35. Novartis AG Autism Diagnostic Product Offerings
Table 36. Novartis AG Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis AG Key News & Latest Developments
Table 38. Allergan Company Summary
Table 39. Allergan Autism Diagnostic Product Offerings
Table 40. Allergan Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 41. Allergan Key News & Latest Developments
Table 42. Merck&Co Inc. Company Summary
Table 43. Merck&Co Inc. Autism Diagnostic Product Offerings
Table 44. Merck&Co Inc. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 45. Merck&Co Inc. Key News & Latest Developments
Table 46. Eli Lilly and Company Company Summary
Table 47. Eli Lilly and Company Autism Diagnostic Product Offerings
Table 48. Eli Lilly and Company Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly and Company Key News & Latest Developments
Table 50. F. Hoffmann-La Roche Ltd. Company Summary
Table 51. F. Hoffmann-La Roche Ltd. Autism Diagnostic Product Offerings
Table 52. F. Hoffmann-La Roche Ltd. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 53. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd. Company Summary
Table 55. Teva Pharmaceutical Industries Ltd. Autism Diagnostic Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 58. Johnson&Johnson Services, Inc. Company Summary
Table 59. Johnson&Johnson Services, Inc. Autism Diagnostic Product Offerings
Table 60. Johnson&Johnson Services, Inc. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson&Johnson Services, Inc. Key News & Latest Developments
Table 62. Bristol–Myer Squibb Company Summary
Table 63. Bristol–Myer Squibb Autism Diagnostic Product Offerings
Table 64. Bristol–Myer Squibb Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol–Myer Squibb Key News & Latest Developments
Table 66. Otsuka Holdings Co., Ltd. Company Summary
Table 67. Otsuka Holdings Co., Ltd. Autism Diagnostic Product Offerings
Table 68. Otsuka Holdings Co., Ltd. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 69. Otsuka Holdings Co., Ltd. Key News & Latest Developments
Table 70. Actavis, Inc. Company Summary
Table 71. Actavis, Inc. Autism Diagnostic Product Offerings
Table 72. Actavis, Inc. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 73. Actavis, Inc. Key News & Latest Developments
Table 74. Curemark LLC. Company Summary
Table 75. Curemark LLC. Autism Diagnostic Product Offerings
Table 76. Curemark LLC. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 77. Curemark LLC. Key News & Latest Developments
Table 78. Mylan Pharmaceuticals Company Summary
Table 79. Mylan Pharmaceuticals Autism Diagnostic Product Offerings
Table 80. Mylan Pharmaceuticals Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 81. Mylan Pharmaceuticals Key News & Latest Developments
Table 82. Asuragen Inc. Company Summary
Table 83. Asuragen Inc. Autism Diagnostic Product Offerings
Table 84. Asuragen Inc. Autism Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 85. Asuragen Inc. Key News & Latest Developments
List of Figures
Figure 1. Autism Diagnostic Segment by Type in 2022
Figure 2. Autism Diagnostic Segment by Application in 2022
Figure 3. Global Autism Diagnostic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autism Diagnostic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Autism Diagnostic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autism Diagnostic Revenue in 2022
Figure 8. By Type - Global Autism Diagnostic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Autism Diagnostic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Autism Diagnostic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Autism Diagnostic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Autism Diagnostic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Autism Diagnostic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Autism Diagnostic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Autism Diagnostic Revenue Market Share, 2018-2029
Figure 16. US Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Autism Diagnostic Revenue Market Share, 2018-2029
Figure 20. Germany Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 21. France Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Autism Diagnostic Revenue Market Share, 2018-2029
Figure 28. China Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 32. India Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Autism Diagnostic Revenue Market Share, 2018-2029
Figure 34. Brazil Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Autism Diagnostic Revenue Market Share, 2018-2029
Figure 37. Turkey Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Autism Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer, Inc. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis AG Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Allergan Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck&Co Inc. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly and Company Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. F. Hoffmann-La Roche Ltd. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceutical Industries Ltd. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson&Johnson Services, Inc. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol–Myer Squibb Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Otsuka Holdings Co., Ltd. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Actavis, Inc. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Curemark LLC. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Mylan Pharmaceuticals Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Asuragen Inc. Autism Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 自閉症診断の世界市場見通し2023年-2029年(Autism Diagnostic Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

自閉症診断の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp